These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1481056)

  • 1. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract]   [Full Text] [Related]  

  • 4. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
    Rosak C; Hofmann U; König P; Nitsche GB
    Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.
    Caspary L; Creutzig A; Alexander K
    Prog Clin Biol Res; 1987; 242():433-8. PubMed ID: 2959965
    [No Abstract]   [Full Text] [Related]  

  • 8. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
    Heidrich H
    Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
    Dé P; Hepp W
    Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
    Weiss T
    Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
    Lynch TG; Hobson RW; Barbalinardo JP; Kerr JC
    Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A; Bruch HP; Hörl M; Düsel W
    Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease].
    Hinderer S; Brachmann R; Nedder KH; Bucher J; Beischer W
    Vasa; 1991; 20(2):100-8. PubMed ID: 1877328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous prostavasin--therapy in peripheral arterial occlusive disease in Fontaine's stages III and IV. Early and late results of a screening study.
    Heidrich H; Meuche C; Ranft J; Rummel S; Peters A
    Prog Clin Biol Res; 1989; 301():411-6. PubMed ID: 2678131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.